Buska Wealth Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Buska Wealth Management’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,131	Closed	-$220K	–	81
2025 Q4	$220K	Sell	2,131 -514	-19%	-$50K	0.08%	71
2025 Q3	$239K	Sell	2,645 -652	-20%	-$57.1K	0.07%	62
2025 Q2	$290K	Sell	3,297 -729	-18%	-$63.2K	0.08%	57
2025 Q1	$367K	Sell	4,026 -1,450	-26%	-$131K	0.12%	48
2024 Q4	$473K	Sell	5,476 -2,238	-29%	-$202K	0.15%	36
2024 Q3	$733K	Buy	+7,714	New	+$733K	0.26%	30

Other funds holding PPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

BCIM

British Columbia Investment Management Victoria, British Columbia, Canada $16B AUM 37.57% 1-Year Est. Return

ERSOT

Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

JSAM

J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return

Buska Wealth Management's PPH Position: Q1 2026 in Review

Buska Wealth Management sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2026, closing a stake of 2,131 shares — an estimated $220K sold.

Buska Wealth Management first reported a position in PPH in Q3 2024 and held it in 6 quarters. The position peaked at $733K in Q3 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

Buska Wealth Management reported no remaining VanEck Pharmaceutical ETF position as of Q1 2026 after selling out during the quarter.
Buska Wealth Management sold 2,131 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $220K.
Buska Wealth Management first reported a position in VanEck Pharmaceutical ETF in Q3 2024 and held it in 6 quarters.
Buska Wealth Management's VanEck Pharmaceutical ETF position peaked at $733K in Q3 2024.
147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Buska Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.